EW operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edwards Lifesciences Operating Expenses — Trailing twelve months (TTM) (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2026	3,248,700,000
Mar 31, 2026	3,176,500,000
Dec 31, 2025	3,118,200,000
Sep 30, 2025	3,040,500,000
Jun 30, 2025	2,996,900,000
Mar 31, 2025	2,961,600,000
Dec 31, 2024	2,930,400,000
Sep 30, 2024	2,808,100,000
Jun 30, 2024	2,691,900,000
Mar 31, 2024	2,622,600,000
Dec 31, 2023	2,635,000,000
Sep 30, 2023	2,619,500,000
Jun 30, 2023	2,605,700,000
Mar 31, 2023	2,611,400,000
Dec 31, 2022	2,512,800,000
Sep 30, 2022	2,526,400,000
Jun 30, 2022	2,517,600,000
Mar 31, 2022	2,457,200,000
Dec 31, 2021	2,396,200,000
Sep 30, 2021	2,273,800,000
Jun 30, 2021	2,174,700,000
Mar 31, 2021	2,033,200,000
Dec 31, 2020	1,991,300,000
Sep 30, 2020	1,998,500,000
Jun 30, 2020	1,997,800,000
Mar 31, 2020	2,040,800,000
Dec 31, 2019	1,996,800,000
Sep 30, 2019	1,906,600,000
Jun 30, 2019	1,835,200,000
Mar 31, 2019	1,762,300,000
Dec 31, 2018	1,708,400,000
Sep 30, 2018	1,669,000,000
Jun 30, 2018	1,625,200,000
Mar 31, 2018	1,575,300,000
Dec 31, 2017	1,535,000,000
Sep 30, 2017	1,471,500,000
Jun 30, 2017	1,426,900,000
Mar 31, 2017	1,390,500,000
Dec 31, 2016	1,347,800,000
Sep 30, 2016	1,319,800,000
Jun 30, 2016	1,290,300,000
Mar 31, 2016	1,260,000,000
Dec 31, 2015	1,233,800,000
Sep 30, 2015	1,220,400,000
Jun 30, 2015	1,217,200,000
Mar 31, 2015	1,210,400,000
Dec 31, 2014	1,204,500,000
Sep 30, 2014	1,166,500,000
Jun 30, 2014	1,121,300,000
Mar 31, 2014	1,086,600,000
Dec 31, 2013	1,068,600,000
Sep 30, 2013	1,052,300,000
Jun 30, 2013	1,029,300,000
Mar 31, 2013	1,015,800,000
Dec 31, 2012	996,600,000
Sep 30, 2012	967,900,000
Jun 30, 2012	953,500,000
Mar 31, 2012	925,200,000
Dec 31, 2011	888,700,000
Sep 30, 2011	862,900,000
Jun 30, 2011	821,400,000
Mar 31, 2011	784,500,000
Dec 31, 2010	754,400,000
Sep 30, 2010	736,700,000
Jun 30, 2010	721,600,000
Mar 31, 2010	701,500,000
Dec 31, 2009	684,100,000
Sep 30, 2009	659,500,000
Jun 30, 2009	643,300,000
Mar 31, 2009	634,100,000
Dec 31, 2008	631,500,000
Sep 30, 2008	623,500,000
Jun 30, 2008	603,200,000
Mar 31, 2008	572,100,000
Dec 31, 2007	539,200,000
Sep 30, 2007	516,300,000
Jun 30, 2007	502,000,000
Mar 31, 2007	497,100,000
Dec 31, 2006	468,800,000
Sep 30, 2006	456,600,000
Jun 30, 2006	446,700,000
Mar 31, 2006	435,100,000
Dec 31, 2005	447,400,000
Sep 30, 2005	440,600,000
Jun 30, 2005	432,300,000
Mar 31, 2005	419,700,000
Dec 31, 2004	422,300,000
Sep 30, 2004	407,400,000
Jun 30, 2004	393,100,000
Mar 31, 2004	388,500,000
Dec 31, 2003	366,000,000
Sep 30, 2003	361,200,000
Jun 30, 2003	410,700,000
Mar 31, 2003	380,900,000
Dec 31, 2002	352,800,000
Sep 30, 2002	331,100,000
Jun 30, 2002	254,400,000
Mar 31, 2002	337,600,000
Dec 31, 2001	344,000,000
Sep 30, 2001	307,200,000